These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 35293602)
1. The role of galectins‑1, 3, 7, 8 and 9 as potential diagnostic and therapeutic markers in ovarian cancer (Review). Mielczarek-Palacz A; Kondera-Anasz Z; Smycz-Kubańska M; Englisz A; Janusz A; Królewska-Daszczyńska P; Wendlocha D Mol Med Rep; 2022 May; 25(5):. PubMed ID: 35293602 [TBL] [Abstract][Full Text] [Related]
2. Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications. Mohamed RM; Emam A; Abdelfattah MM; Abdel-Mageed AI; Abdelhafeez MA; Helwa R World J Surg Oncol; 2022 Sep; 20(1):276. PubMed ID: 36050693 [TBL] [Abstract][Full Text] [Related]
3. Glycans and galectins in prostate cancer biology, angiogenesis and metastasis. Compagno D; Gentilini LD; Jaworski FM; Pérez IG; Contrufo G; Laderach DJ Glycobiology; 2014 Oct; 24(10):899-906. PubMed ID: 24939371 [TBL] [Abstract][Full Text] [Related]
4. Galectins-1, -3, -7, -8 and -9 as prognostic markers for survival in epithelial ovarian cancer: A systematic review and meta-analysis. Pergialiotis V; Papoutsi E; Androutsou A; Tzortzis AS; Frountzas M; Papapanagiotou A; Kontzoglou K Int J Gynaecol Obstet; 2021 Mar; 152(3):299-307. PubMed ID: 33156523 [TBL] [Abstract][Full Text] [Related]
5. Galectins as pivotal components in oncogenesis and immune exclusion in human malignancies. Kapetanakis NI; Busson P Front Immunol; 2023; 14():1145268. PubMed ID: 36817445 [TBL] [Abstract][Full Text] [Related]
6. Galectins and Carcinogenesis: Their Role in Head and Neck Carcinomas and Thyroid Carcinomas. Kindt N; Journe F; Ghanem GE; Saussez S Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29258258 [TBL] [Abstract][Full Text] [Related]
7. Vascular galectins in tumor angiogenesis and cancer immunity. Thijssen VLJL Semin Immunopathol; 2024 Jul; 46(1-2):3. PubMed ID: 38990363 [TBL] [Abstract][Full Text] [Related]
8. Galectins: Multitask signaling molecules linking fibroblast, endothelial and immune cell programs in the tumor microenvironment. Elola MT; Ferragut F; Méndez-Huergo SP; Croci DO; Bracalente C; Rabinovich GA Cell Immunol; 2018 Nov; 333():34-45. PubMed ID: 29602445 [TBL] [Abstract][Full Text] [Related]
9. [Galectins in hematological malignancies--role, functions and potential therapeutic targets]. Wdowiak K; Spychałowicz W; Fajkis M; Wojnar J Postepy Hig Med Dosw (Online); 2016 Feb; 70():95-103. PubMed ID: 26943306 [TBL] [Abstract][Full Text] [Related]
10. Galectins in the tumor endothelium: opportunities for combined cancer therapy. Thijssen VL; Poirier F; Baum LG; Griffioen AW Blood; 2007 Oct; 110(8):2819-27. PubMed ID: 17591944 [TBL] [Abstract][Full Text] [Related]
11. Galectins and neovascularization in central nervous system tumors. D'Haene N; Maris C; Rorive S; Decaestecker C; Le Mercier M; Salmon I Glycobiology; 2014 Oct; 24(10):892-8. PubMed ID: 24861052 [TBL] [Abstract][Full Text] [Related]
12. Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression. Girotti MR; Salatino M; Dalotto-Moreno T; Rabinovich GA J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31873723 [TBL] [Abstract][Full Text] [Related]
13. Role of Human Galectins in Inflammation and Cancers Associated with Endometriosis. Hisrich BV; Young RB; Sansone AM; Bowens Z; Green LJ; Lessey BA; Blenda AV Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32033052 [TBL] [Abstract][Full Text] [Related]
14. Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives. Wdowiak K; Francuz T; Gallego-Colon E; Ruiz-Agamez N; Kubeczko M; Grochoła I; Wojnar J Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29320431 [TBL] [Abstract][Full Text] [Related]
15. Galectin-1 and -9 in angiogenesis: a sweet couple. Thijssen VL; Griffioen AW Glycobiology; 2014 Oct; 24(10):915-20. PubMed ID: 24861051 [TBL] [Abstract][Full Text] [Related]
16. Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients. Schulz H; Schmoeckel E; Kuhn C; Hofmann S; Mayr D; Mahner S; Jeschke U Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28594391 [TBL] [Abstract][Full Text] [Related]
17. Migration-inducing gene 7 promotes tumorigenesis and angiogenesis and independently predicts poor prognosis of epithelial ovarian cancer. Huang B; Yin M; Li X; Cao G; Qi J; Lou G; Sheng S; Kou J; Chen K; Yu B Oncotarget; 2016 May; 7(19):27552-66. PubMed ID: 27050277 [TBL] [Abstract][Full Text] [Related]
18. Markers of angiogenesis in ovarian cancer. Merritt WM; Sood AK Dis Markers; 2007; 23(5-6):419-31. PubMed ID: 18057525 [TBL] [Abstract][Full Text] [Related]
19. Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9. Schulz H; Kuhn C; Hofmann S; Mayr D; Mahner S; Jeschke U; Schmoeckel E Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29361803 [TBL] [Abstract][Full Text] [Related]
20. The emerging role of galectins in cardiovascular disease. van der Hoeven NW; Hollander MR; Yıldırım C; Jansen MF; Teunissen PF; Horrevoets AJ; van der Pouw Kraan TC; van Royen N Vascul Pharmacol; 2016 Jun; 81():31-41. PubMed ID: 26945624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]